Cargando…

Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile

BACKGROUND: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is known. However, there are no validated screening instruments that also assess risk and protective factors for this population in Chile, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez, Saray, Gana, Sofía, Godoy, María Inés, Valenzuela, Daniela, Araya, Ricardo, Gaete, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504767/
https://www.ncbi.nlm.nih.gov/pubmed/34634082
http://dx.doi.org/10.1371/journal.pone.0258288
_version_ 1784581387981946880
author Ramírez, Saray
Gana, Sofía
Godoy, María Inés
Valenzuela, Daniela
Araya, Ricardo
Gaete, Jorge
author_facet Ramírez, Saray
Gana, Sofía
Godoy, María Inés
Valenzuela, Daniela
Araya, Ricardo
Gaete, Jorge
author_sort Ramírez, Saray
collection PubMed
description BACKGROUND: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is known. However, there are no validated screening instruments that also assess risk and protective factors for this population in Chile, which is essential for evaluating future prevention interventions. OBJECTIVE: To determine the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) questionnaire. METHODS: A cross-sectional study was carried out in 13 schools in the city of Santiago de Chile. The sample included 2261 adolescents ranging from 10 to 14 years old. Linguistic and cultural adaptation was assessed using focus groups with adolescents, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood and seemed to adequately capture the consumption of different drugs. Regarding the subscales of risk and protective factors, the analyses showed that most subscales had good psychometric properties, and few needed some degree of improvement (e.g., some items were removed). After the changes, most final subscales had good or adequate goodness of fit adjustments and good or acceptable internal consistency. Finally, the main associated factors with the substance use outcomes were: future substance use and school bonding for tobacco use; negative beliefs about alcohol, future substance use, school bonding and refusal skills for alcohol use; and negative beliefs about marihuana, positive attitudes towards drugs, risk perception, and substance abuse index for marihuana use. Normative beliefs increased the risk for all substances use. CONCLUSIONS: The current findings suggest that the EU-Dap is a valid and reliable instrument, and it may help to evaluate the effectiveness of drug use prevention interventions.
format Online
Article
Text
id pubmed-8504767
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85047672021-10-12 Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile Ramírez, Saray Gana, Sofía Godoy, María Inés Valenzuela, Daniela Araya, Ricardo Gaete, Jorge PLoS One Research Article BACKGROUND: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is known. However, there are no validated screening instruments that also assess risk and protective factors for this population in Chile, which is essential for evaluating future prevention interventions. OBJECTIVE: To determine the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) questionnaire. METHODS: A cross-sectional study was carried out in 13 schools in the city of Santiago de Chile. The sample included 2261 adolescents ranging from 10 to 14 years old. Linguistic and cultural adaptation was assessed using focus groups with adolescents, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood and seemed to adequately capture the consumption of different drugs. Regarding the subscales of risk and protective factors, the analyses showed that most subscales had good psychometric properties, and few needed some degree of improvement (e.g., some items were removed). After the changes, most final subscales had good or adequate goodness of fit adjustments and good or acceptable internal consistency. Finally, the main associated factors with the substance use outcomes were: future substance use and school bonding for tobacco use; negative beliefs about alcohol, future substance use, school bonding and refusal skills for alcohol use; and negative beliefs about marihuana, positive attitudes towards drugs, risk perception, and substance abuse index for marihuana use. Normative beliefs increased the risk for all substances use. CONCLUSIONS: The current findings suggest that the EU-Dap is a valid and reliable instrument, and it may help to evaluate the effectiveness of drug use prevention interventions. Public Library of Science 2021-10-11 /pmc/articles/PMC8504767/ /pubmed/34634082 http://dx.doi.org/10.1371/journal.pone.0258288 Text en © 2021 Ramírez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ramírez, Saray
Gana, Sofía
Godoy, María Inés
Valenzuela, Daniela
Araya, Ricardo
Gaete, Jorge
Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title_full Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title_fullStr Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title_full_unstemmed Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title_short Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile
title_sort validation of the european drug addiction prevention trial questionnaire (eu-dap) for substance use screening and to assess risk and protective factors among early adolescents in chile
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504767/
https://www.ncbi.nlm.nih.gov/pubmed/34634082
http://dx.doi.org/10.1371/journal.pone.0258288
work_keys_str_mv AT ramirezsaray validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile
AT ganasofia validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile
AT godoymariaines validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile
AT valenzueladaniela validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile
AT arayaricardo validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile
AT gaetejorge validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongearlyadolescentsinchile